WELL-INTEGRATED SCREENING AND EVALUATION FOR WOMEN ACROSS THE NATION (WISEWOMAN)

The purpose of this competitive five-year program is to fund state health departments and tribal organizations to extend services to improve prevention, detection, and control of CVD risk factors for low-income, uninsured, or underinsured women by offering CVD screening, risk reduction counseling, referral
to medical services, referral to programs, and resources to support positive cardiovascular health.

Agency - Department of Health and Human Services

The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.

Website Address

http://www.cdc.gov




Selected Recipients for this Program


RecipientAmount Start DateEnd Date
Health, Washington State Department Of $ 700,000   2018-09-302023-09-29
Health & Human Services, Michigan Department Of $ 870,000   2018-09-302023-09-29
Department Of Health Utah $ 1,100,000   2018-09-302023-09-29
Public Health, Alabama Department Of $ 900,000   2018-09-302023-09-29
Public Health, Iowa Department Of $ 700,000   2018-09-302023-09-29
Health & Human Services, North Carolina Department Of $ 940,000   2018-09-302023-09-29
Southcentral Foundation $ 550,000   2018-09-302023-09-29
Public Health, Connecticut Department Of $ 695,000   2018-09-302023-09-29
Arkansas Department Of Health $ 500,000   2018-09-302023-09-29
Health, Louisiana Department Of $ 500,000   2018-09-302023-09-29



Program Accomplishments

Not Applicable.

Uses and Use Restrictions

Funds can be used for salaries for personnel to plan, implement, monitor and evaluate the program activities; for contracts or agreements with clinical entities to provide the cardiovascular screenings; risk reduction counseling; diagnostic office visits for abnormal screening values; contracts or agreements with community based organizations to provide health education and lifestyle support programs, or to improve the health of the physical environment (for example to improve access to healthy food, physical activity, or decrease tobacco exposure); or other activities that promote or support healthy behaviors and improved cardiovascular health in women.

Funds can be used to pay for activities or expendable equipment necessary to provide the services outlined here, including self-blood pressure monitoring equipment and counseling to enhance medication adherence.

Funds can be used to develop and maintain data collection systems to collect and report biomeasures and behavior information and for monitoring systems to augment control of hypertension.

Funds cannot be used for research or construction or for ongoing medical treatment of participants. In accordance with Public Law 101-354 and its amendments, at least 60 percent of cooperative agreement funds awarded must be used to provide direct client services for eligible women.

Direct client services include screening; health education/lifestyle intervention sessions; diagnostic tests; laboratory fees; tracking; follow-up; and support services to maximize participation in screening and lifestyle intervention sessions.

No more than 40 percent of cooperative agreement funds can be used to support the following: program management and planning; data management, which includes using data to track due dates or attendance at appointments; quality assurance/quality improvement; public education initiatives; professional development; partnerships; community engagement; evaluation; and administration.

Administrative costs are limited to no more than 10% of the total amount awarded. Recipient financial participation is required for this program in accordance with the authorizing legislation.

Section 1502(a) and (b)(1), (2), and (3) of the PHS Act, as amended, requires matching funds from non-Federal sources in an amount not less than one dollar for every three dollars of Federal funds awarded under this program.

However, Title 48 of the US Code 1469a (d) requires DHHS to waive matching fund requirements for Guam, U. S. Virgin Islands, American Samoa, and the Commonwealth of the Northern Mariana Islands up to $200,000.

The match requirement may include third-party in-kind contributions, as well as expenditures from the grantee.

The matching funds may be cash, in-kind or donated services or equipment.

Public Law 93-638 authorizes tribal organizations contracting under the authority of Title I to use funds received under the Indian Self-Determination Act as matching funds.

Matching funds may not include: 1) payment for treatment services or the donation of treatment services; 2) services assisted or subsidized by the Federal government; or 3) the indirect or overhead costs of an organization.

All costs designated as meeting the match requirement must be documented by the applicant and will be subject to audit.

Documentation of appropriate matching is to be provided in the detailed budget and narrative justification.

Eligibility Requirements

Applicant Eligibility

State and the District of Columbia government; local government or their Bona Fide Agent; U.S.

Territory or Possession; Federally Recognized Indian Tribal Government; Native American Organization (American Indian/Alaska native tribally designated organization). 1. Eligible Applicants: ? State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) .

? American Indian/Alaska Native tribal governments (federally recognized or state-recognized) ? American Indian/Alaska native tribally designated organizations 2. Special Eligibility Requirements: Applicants must be recipients of the NBCCEDP program funding.

Beneficiary Eligibility

Beneficiaries of this program include: Women who are ages 40-64 and eligible through the National Breast and Cervical Cancer Early Detection Program criteria.

Credentials/Documentation

No Credentials or documentation are required. This program is excluded from coverage under 2 CFR 200, Subpart E - Cost Principles.

Aplication and Award Process

Preapplication Coordination

Preapplication coordination is required.

Environmental impact information is not required for this program.

This program is eligible for coverage under E.O.

12372, 'Intergovernmental Review of Federal Programs.' An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.

Application Procedures

2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program.

Award Procedures

Review and Selection Process: Applications will be reviewed in three phases. Phase I Review: All applications will be reviewed initially for completeness by CDC OGS staff and will be reviewed jointly for eligibility by the CDC National Center for Chronic Disease Prevention and Health Promotion and CDC OGS. Incomplete applications that do not meet the eligibility criteria will not advance to Phase II review. Phase II Review: This funding opportunity is comprised of two components ? Core Component and Innovation Component. Core Component: This competitive Core Component will support the implementation and evaluation of a core set of evidence-based strategies designed to reduce risks, complications, and barriers to the prevention and control of heart disease and stroke among the target population. Applicants must propose a comprehensive work plan that addresses hypertension in alignment with the following broad Strategies indicated in the NOFO. Applicants for the Core Component must propose criteria for selection of health systems and communities in which to work, based on a robust analysis of overall health burden and across population subgroups. Proposals must include clinical and community partners that will support the delivery of services. Letters of support with a firm commitment from providers and partners should be included in the application. Innovation Component: This competitive Innovation Component will support the implementation and evaluation of a small set of innovative strategies designed to reduce risks, complications, and barriers to the prevention and control of heart disease and stroke. All applicants must apply for the Core Component in order to be considered for the Innovation Component. Only those successful applicants under the Core Component will be eligible for Innovation Component funding. Applicants must apply for Innovation Component funding at the same time they make application for Core Component funding. Phase III Review: Applications submitted under the Core Component will be funded by score and rank as determined by the objective review panel. Applications submitted under the Innovation Component will be funded by score and rank determined by the objective review panel. The Selecting official shall rely on the rank order established by the objective review panel as the primary factor in making awards.

Deadlines

Contact the headquarters or regional office, as appropriate, for application deadlines.

Authorization

This program is authorized under 42 U.S.C. 300l-1 (2012), sections 1501-1510 [42 U.S.C. 300k, 42 U.S.C. 300l, 42 U.S.C. 300m, 42 U.S.C. 300n, 42 U.S.C. 300 n-1, 42 U.S.C. 300 n-2, 42 U.S.C. 300 n-3, 42 U.S.C. 300 n-4, 42 U.S.C. 300 n-4a, 42 U.S.C. 300 n-5] of the Public Health Service Act, as amended. WISEWOMAN must follow the legislative requirements detailed in these sections.

Range of Approval/Disapproval Time

From 120 to 180 days.

Appeals

Not Applicable.

Renewals

From 90 to 120 days.

Assistance Considerations

Formula and Matching Requirements

This program has no statutory formula. Matching Requirements: In preparing budgets, applicants must include financial participation described below. Recipient financial participation is required for this program in accordance with the authorizing legislation. Section 1502(a) and (b)(1), (2), and (3) of the PHS Act, as amended, requires matching funds from non-Federal sources in an amount not less than one dollar for every three dollars of Federal funds, a ratio of 3:1, awarded under this program. However, Title 48 of the US Code 1469a (d) requires DHHS to waive matching fund requirements for Guam, U.S. Virgin Islands, American Samoa, and the Commonwealth of the Northern Mariana Islands up to $200,000. The match requirement may include third-party in-kind contributions, as well as expenditures from the grantee. The matching funds may be cash, in-kind or donated services or equipment. Public Law 93-638 authorizes tribal organizations contracting under the authority of Title I to use funds received under the Indian Self-Determination Act as matching funds. Matching funds may not include: 1) payment for treatment services or the donation of treatment services; 2) services assisted or subsidized by the Federal government; or 3) the indirect or overhead costs of an organization. All costs designated as meeting the match requirement must be documented by the applicant and will be subject to audit. Documentation of appropriate matching is to be provided in the detailed budget and narrative justification. MOE requirements are not applicable to this program.

Length and Time Phasing of Assistance

Funding for this program will be awarded on annual basis and the funding will be available for obligation by recipients for a period of 12-months. Method of awarding/releasing assistance: lump sum.

Post Assistance Requirements

Reports

Awardees will be expected to provide reports so that CDC can provide continuous program monitoring.

These reports identify successes and challenges that awardees encounter throughout the project period.

Also, reporting is a requirement for awardees who want to apply for yearly continuation of funding.

Awardees will be expected to submit annual performance reports, ongoing performance measure data, administrative reports, and a final performance and financial report.

A detailed explanation of any additional reporting requirements will be provided in the notice of award to successful applicants.

Cash Reports are required to be submitted to the HHS Payment Management System per HHS Policy.

Progress reports are required on annual basis.

Awardees will submit Annual Federal Financial Reports using the SF-425.

These reports are required and must be submitted to the CDC Grants Management Officer no later than 90-days after the end of each budget period.

Annual performance progress and monitoring reports will be expected from all awardees no later than 120 days prior to the end of each budget period.

This report will serve as the continuation application for the follow-on budget period.

The contents of the report should include the information specified in the solicitation from the CDC Grants Management Officer.

Audits

In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503.

Records

CDC requires awardees to meet all record retention requirements defined in the notice of award, the funding opportunity, the HHS grants policy statement, and 45 CFR Part 75.

Financial Information

Account Identification

75-0943-0-1-550.

Obigations

(Cooperative Agreements (Discretionary Grants)) FY 17 $14,549,174; FY 18 est $15,000,000; and FY 19 est $15,000,000

Range and Average of Financial Assistance

Awards are expected to range from $500,000 to $2,500,000 (total award for both Core and innovation Components, were applicable). All activities supported through this NOFO must contribute to health improvements across the target population and across population subgroups. Award recipients must demonstrate significant disease burden to allow the strategies supported by this NOFO to reach a significant proportion of the target population. Funding strategy will also include the awardees? proposed activities and goals, estimated population reach, and program capacity as described in the application.

Regulations, Guidelines, and Literature

Not Applicable.

Information Contacts

Regional or Local Office

None.

Headquarters Office

Rebekah Buckley 4770 Buford Highway, MS-F75, Atlanta, Georgia 30341 Email: eut9@cdc.gov Phone: 7704886215

Criteria for Selecting Proposals

Review and Selection Process: Applications will be reviewed in three phases. Phase I Review: All applications will be reviewed initially for completeness by CDC OGS staff and will be reviewed jointly for eligibility by the CDC National Center for Chronic Disease Prevention and Health Promotion and CDC OGS. Incomplete applications that do not meet the eligibility criteria will not advance to Phase II review. Phase II Review: This funding opportunity is comprised of two components ? Core Component and Innovation Component. Core Component: This competitive Core Component will support the implementation and evaluation of a core set of evidence-based strategies designed to reduce risks, complications, and barriers to the prevention and control of heart disease and stroke among the target population. Applicants must propose a comprehensive work plan that addresses hypertension in alignment with the following broad Strategies indicated in the NOFO. Applicants for the Core Component must propose criteria for selection of health systems and communities in which to work, based on a robust analysis of overall health burden and across population subgroups. Proposals must include clinical and community partners that will support the delivery of services. Letters of support with a firm commitment from providers and partners should be included in the application. Innovation Component: This competitive Innovation Component will support the implementation and evaluation of a small set of innovative strategies designed to reduce risks, complications, and barriers to the prevention and control of heart disease and stroke. All applicants must apply for the Core Component in order to be considered for the Innovation Component. Only those successful applicants under the Core Component will be eligible for Innovation Component funding. Applicants must apply for Innovation Component funding at the same time they make application for Core Component funding. Phase III Review: Applications submitted under the Core Component will be funded by score and rank as determined by the objective review panel. Applications submitted under the Innovation Component will be funded by score and rank determined by the objective review panel. The Selecting official shall rely on the rank order established by the objective review panel as the primary factor in making awards.



More Federal Domestic Assistance Programs


Indian Self-Determination Contract Support | Mine Health and Safety Education and Training | Youth Conservation Services | Capacity Building for Non-Land Grant Colleges of Agriculture (NLGCA) | Congressionally Directed Assistance |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2019 Copyright Michael Saunders